Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.625    0.00 (0.00%)
Bid:
5.50
Ask:
5.75
Spread: 0.25 (4.545%)
Market Cap: £5.00m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Trading Update

14 May 2020 09:44

RNS Number : 9046M
Coral Products PLC
14 May 2020
 

14 May 2020

CORAL PRODUCTS PLC

('Coral' or the 'Company' or the 'Group')

 

Trading Update - Year to 30 April 2020

 

The board of Coral Products PLC, a specialist in the design, manufacture and supply of plastic products is pleased to provide the following update to its previous announcement of 24 March 2020.

 

Summary of results

 

The board reports that on sales of circa £22.3m (2019: £24.7m) it expects, a small loss before taxation and intangibles for the full year and a small drop in EBITDA from the previous year as stated in our half-year statement, notwithstanding the negative effects of the ongoing Covid-19 crisis.

 

Operations

 

The unaudited annual results were marginally affected by the Covid-19 pandemic in March 2020 but a significant impact was noted in April 2020 as the following sales analysis shows:

 

April Sales as a % of Pre Covid-19 Average:

 

 

Group

70%

Coral Products (Mouldings) Ltd

90%

Injection and Blow Moulding

Interpack Ltd

60%

Food Packaging

Tatra Rotalac Ltd

60%

Extrusions

Global One Pak Ltd

40%

Nozzles, Sprays and Caps

 

We are planning for a medium-term level return of demand as a group of around 65% of pre Covid-19 levels though the mix may vary.

 

A good example is Global One Pak Ltd, who are reliant on Chinese imports, where management has moved quickly to change product mix and negotiated new supply terms with customers and suppliers resulting in a record order intake during late April 2020 for delivery from August 2020 and well into 2021.

 

As the restrictions on the general populace are eased, we believe there will be improved demand for our food packaging operations.

 

Moulding operations remain somewhat reduced as regards to injection moulding demand but this is being partially offset by an increased demand in blow moulding.

 

Extrusions is more difficult to forecast as this is determined by economic activity generally.

 

With the uncertainty remaining from the current pandemic we feel unable, with any confidence, to offer guidance for financial performance for the new financial year to 30 April 2021. We continue to monitor and update our performance and are encouraged by our Group's resilient performance to date.

 

Covid-19

 

We are grateful for the government support on offer and where appropriate have availed ourselves of the assistance offered by the payroll protection furlough scheme as well as VAT deferral.

 

Where possible we have also encouraged staff, who remain on the payroll to work from home. All staff members and your board have reduced salaries by 20% for April 2020 and May 2020 which may continue subject to review.

 

In addition, we have negotiated capital holidays ranging from 3 to 6 months with the majority of our asset finance and other lenders. We appreciate this support.

 

We have negotiated a three-year CBIL (Coronavirus Business Interruption Loan) for £1 million pounds, with a 7-month capital repayment holiday, at an interest rate of 4.5% over base, 12 months interest free from the Company's existing bank - Barclays. The existing security arrangements with Barclays will continue, no additional security has been provided by the Company.

 

The loan proceeds were received in our account on 13 May 2020.

 

 

We would like to express our thanks to our Barclays bank relationship counterparts whose guidance and assistance were invaluable.

 

Your board had already taken steps to improve the Company's working capital to aid our pre Covid-19 forecast demand by determining to sell and leaseback the freehold Haydock premises. The subsequent crisis and the inability of surveyors and prospective purchasers to inspect has meant the sale is now on hold until the crisis passes. The book value of this property is £2.5 million and carries a bank loan of £1.75 million. The Company expect to realise sale proceeds in excess of the property's book value.

 

Outlook

 

The actions taken by the board, the continuing resilience of our employees and in the absence of any future government mandated shutdown, give us confidence that we have the means to come through this current crisis.

 

The board recognise its responsibility to provide safe and healthy working conditions to all of the Company's stakeholders and will work to ensure such conditions are forefront when we return to more normal working conditions.

 

We will continue to monitor the performance of our Group and the economic circumstances in general as this crisis unfolds. We will provide updates to the market as appropriate.

 

 

 

This announcement contains inside information for the purpose of Article 7 of the EU Regulation 596/2014 and has been arranged for release by Sharon Gramauskas, Finance Director of the Company.

 

 

For further information, please contact:

 

Coral Products plc

Michael (Mick) Wood, Chief Executive Officer

 

 

Tel: 07788 565 154

 

Nominated Adviser & Broker

Cairn Financial Advisers LLP

Liam Murray

Tony Rawlinson

David Lawman (Corporate Broking)

 

Tel: 020 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFFSALESSELI
Date   Source Headline
20th Apr 20264:15 pmRNSDirector/PDMR Shareholding
20th Apr 202612:20 pmRNSTrading Update
16th Feb 20267:00 amRNSAcquisition of the assets of AAC Cyroma Limited
8th Jan 20267:00 amRNSHalf-year Financial Report
26th Nov 20254:45 pmRNSResult of AGM & Directorate Change
26th Nov 20257:00 amRNSAGM Statement
31st Oct 202512:00 pmRNSNotice of AGM and Posting of Annual Report
31st Oct 20257:00 amRNSFinal Results
28th Aug 20253:50 pmRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
10th Jul 20258:58 amRNSDirectorate Change
8th Jul 202510:08 amRNSIssue of Options
7th Jul 202510:08 amRNSFull Year Trading Update and Acquisition Update
30th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirectorate Change
4th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:15 pmRNSDirector/PDMR Shareholding
1st Apr 20253:50 pmRNSAcquisition of the assets of Arrow Film Converters
20th Mar 202511:00 amRNSIce Cream & Food Container three-year Agreement
4th Mar 20257:00 amRNSRenewal of Contract
27th Feb 202512:57 pmRNSDirector/PDMR Shareholding
26th Feb 202511:07 amRNSDirector/PDMR Shareholding
21st Feb 202511:02 amRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSCompletion of Property Sale and Directorate Change
3rd Feb 20257:00 amRNSChange of Adviser
28th Jan 20254:35 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSHalf-year Report
7th Jan 20257:00 amRNSProperty Sales and Insurance Claim Settlement
4th Dec 20247:00 amRNSDirectorate Change
12th Nov 20247:00 amRNSDirectorate Change
25th Oct 20247:00 amRNSDirectorate Change
23rd Oct 20244:30 pmRNSResult of General Meeting
14th Oct 20247:00 amRNSTrading Statement
17th Sep 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSSale and Leaseback of Runcorn Factory Site
11th Jun 20247:00 amRNSTrading Statement
23rd May 20245:45 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSDirector/PDMR Shareholding
22nd May 20246:20 pmRNSTransaction in Own Shares
13th May 20244:30 pmRNSDirector/PDMR Shareholding
9th May 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.